CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 138 filers reported holding CARA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,426,060 | +496.1% | 848,845 | +904.2% | 0.29% | +551.1% |
| Q2 2023 | $239,220 | -42.4% | 84,530 | 0.0% | 0.04% | -43.8% |
| Q1 2023 | $415,042 | -49.4% | 84,530 | +10.8% | 0.08% | -52.4% |
| Q4 2022 | $819,731 | +20.7% | 76,325 | +5.2% | 0.17% | +9.8% |
| Q3 2022 | $679,000 | -44.0% | 72,529 | -45.4% | 0.15% | -36.2% |
| Q2 2022 | $1,213,000 | -21.1% | 132,879 | +5.0% | 0.24% | -4.4% |
| Q1 2022 | $1,537,000 | -27.9% | 126,507 | -27.7% | 0.25% | -23.2% |
| Q4 2021 | $2,131,000 | -11.9% | 174,948 | +11.7% | 0.33% | -11.4% |
| Q3 2021 | $2,420,000 | +129.4% | 156,625 | +111.9% | 0.37% | +129.2% |
| Q2 2021 | $1,055,000 | -12.3% | 73,902 | +33.4% | 0.16% | -24.1% |
| Q1 2021 | $1,203,000 | +362.7% | 55,397 | +222.4% | 0.21% | +253.3% |
| Q4 2020 | $260,000 | – | 17,184 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,655,576 | $4,685,280 | 0.73% |
| Bain Capital Life Sciences Investors, LLC | 934,898 | $2,645,761 | 0.27% |
| FNY Investment Advisers, LLC | 35,000 | $99 | 0.12% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,764,201 | $4,992,689 | 0.11% |
| Ergoteles LLC | 358,275 | $1,013,918 | 0.05% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $239,220 | 0.04% |
| PDT Partners, LLC | 85,088 | $240,799 | 0.03% |
| PINNACLE ASSOCIATES LTD | 672,440 | $1,903,005 | 0.03% |
| Alpine Global Management, LLC | 34,014 | $96,260 | 0.03% |
| XTX Topco Ltd | 52,025 | $147,231 | 0.03% |